Nano-X Imaging (NNOX) GM Ofir Koren details option and RSU holdings

Rhea-AI Filing Summary

Nano-X Imaging Ltd. executive Ofir Koren, General Manager of the ARC Division, filed an initial ownership report showing direct holdings of ordinary shares and stock options. The filing lists stock options over 100,000, 25,000 and 33,500 ordinary shares with exercise prices of $49.6800, $17.6300 and $11.5200, expiring between 2031 and 2033. It also describes restricted share units granted in April 2024 and February 2026, which vest over time in scheduled installments.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Koren Ofir

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Manager, ARC Division

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	10,000	D
Ordinary shares(1)	10,000	D
Ordinary shares(2)	39,474	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	(3)	01/18/2031	Ordinary shares	100,000	$49.68	D
Stock Option (right to buy ordinary shares)	(4)	03/28/2032	Ordinary shares	25,000	$17.63	D
Stock Option (right to buy ordinary shares)	(5)	05/23/2033	Ordinary shares	33,500	$11.52	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of the remaining unsold shares underlying 20,000 restricted share units ("RSUs") that were granted to the Reporting Person on April 16, 2024 and that vest in 16 equal quarterly installments of 6.25% each (1,250 RSUs) on each three-month anniversary of the grant date, such that all RSUs reported in this row will be exercisable by the four-year anniversary of the grant date (April 16, 2028).

2. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on February 5, 2026, of which 50% vest on the 12-month anniversary of the grant date and the remaining 50% vest on the 24-month anniversary of the grant date.

3. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.

4. 4. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (March 28, 2026).

5. 5. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).

Remarks:

Exhibit 24.1 Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Nano-X Imaging (NNOX) Form 3 for Ofir Koren report?

The Form 3 reports Ofir Koren’s initial ownership in Nano-X Imaging, including ordinary shares, stock options over 158,500 underlying shares, and time-based restricted share units that vest over several years according to specified schedules.

How many Nano-X Imaging (NNOX) options does Ofir Koren hold?

Ofir Koren holds stock options linked to 100,000, 25,000 and 33,500 Nano-X ordinary shares. These options have exercise prices of $49.6800, $17.6300 and $11.5200 and expire between January 2031 and May 2033.

What restricted share units are disclosed for Nano-X Imaging (NNOX) executive Ofir Koren?

The filing notes 20,000 RSUs granted on April 16, 2024, vesting in 16 quarterly installments of 6.25%, and additional RSUs granted on February 5, 2026, with 50% vesting after 12 months and 50% after 24 months.

Are there buy or sell transactions in Nano-X Imaging (NNOX) Form 3 for Ofir Koren?

The Form 3 functions as an initial ownership statement. It lists holdings of ordinary shares, options and RSUs for Ofir Koren, rather than reporting open-market purchases or sales, which would typically appear on later Forms 4 or 5.

What direct ordinary share holdings does Ofir Koren report in Nano-X Imaging (NNOX)?

The report shows several lines of direct ordinary share ownership, including amounts such as 10,000 and 39,474 shares. Footnotes explain that some of these relate to shares underlying restricted share units that vest over time according to the company’s grant terms.